Explore the words cloud of the LimitMDR project. It provides you a very rough idea of what is the project "LimitMDR" about.
The following table provides information about the project.
DANMARKS TEKNISKE UNIVERSITET
|Coordinator Country||Denmark [DK]|
|Total cost||1˙492˙453 €|
|EC max contribution||1˙492˙453 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2015-05-01 to 2020-04-30|
Take a look of project's partnership.
|1||DANMARKS TEKNISKE UNIVERSITET||DK (KGS LYNGBY)||coordinator||1˙492˙453.00|
Drug resistance is limiting our ability to treat most infectious diseases and forms of cancer. Indeed this relentless evolution is the major driver of treatment failure for diseases that are responsible for over half of the global disease related mortality. Yet, the underlying principles that guide this evolutionary response are poorly understood, in particular with regards to understanding the impact of multidrug treatment. LimitMDR will characterize evolutionary trajectories leading to multidrug resistance in response to individual and combination drug treatment through the execution of large-scale adaptive evolution experiment with two bacterial pathogens followed by genome sequencing and phenotyping. This effort will enable testing of contrasting hypotheses regarding the evolution of multidrug resistance in response to combination treatment.
We will characterize the cause-and-effect of resistance and sensitivity mutations identified in our global data set and map comprehensive fitness landscapes of mutations accumulated during drug resistance evolution to understand the evolutionary dynamics underlying resistance evolution. To accomplish these bold goals we shall develop novel multiplexed methodologies enabling unprecedented scale of construction and phenotypic testing of identified mutations. While genetic epistasis is considered of key importance to resistance evolution most studies focus on mutations within an individual gene. Through the development of a novel experimental approach we shall elucidate complex epistatic interaction networks between mutations accumulated during resistance evolution.
Finally, we will conduct mechanistic studies to uncover the mechanisms of collateral sensitivity. These studies will shed light on this underappreciated phenomenon, which is of critical relevance to drug discovery and the evolution of drug resistance. In conclusion LimitMDR will develop groundbreaking novel methodologies and scientific insights that will c
|year||authors and title||journal||last update|
Carola E. H. Rosenkilde, Christian Munck, Andreas Porse, Marius Linkevicius, Dan I. Andersson, Morten O. A. Sommer
Collateral sensitivity constrains resistance evolution of the CTX-M-15 Î²-lactamase
published pages: 618, ISSN: 2041-1723, DOI: 10.1038/s41467-019-08529-y
|Nature Communications 10/1||2020-02-13|
Morten O. A. Sommer, Christian Munck, Rasmus Vendler Toft-Kehler, Dan I. Andersson
Prediction of antibiotic resistance: time for a new preclinical paradigm?
published pages: 689-696, ISSN: 1740-1526, DOI: 10.1038/nrmicro.2017.75
|Nature Reviews Microbiology 15/11||2020-02-13|
Andreas Porse, Thea S. Schou, Christian Munck, Mostafa M. H. Ellabaan, Morten O. A. Sommer
Biochemical mechanisms determine the functional compatibility of heterologous genes
published pages: 522, ISSN: 2041-1723, DOI: 10.1038/s41467-018-02944-3
|Nature Communications 9/1||2020-02-13|
Munck, Christian; Ellabaan, Mostafa; Klausen, Michael; Sommer, Morten
The resistome of common human pathogens
published pages: 26, ISSN: , DOI: 10.1101/140194
Leonie Johanna Jahn, Andreas Porse, Christian Munck, Daniel Simon, Svetlana Volkova, Morten Otto Alexander Sommer
Chromosomal barcoding as a tool for multiplexed phenotypic characterization of laboratory evolved lineages
published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-018-25201-5
|Scientific Reports 8/1||2020-02-13|
Lejla Imamovic, Maria-Anna Misiakou, Eric van der Helm, Gianni Panagiotou, Maite Muniesa, Morten Otto Alexander Sommer
Complete Genome Sequence of Escherichia coli Strain WG5
published pages: e01403-17, ISSN: 2169-8287, DOI: 10.1128/genomeA.01403-17
|Genome Announcements 6/2||2019-05-29|
Andreas Porse, Heidi Gumpert, Jessica Z. Kubicek-Sutherland, Nahid Karami, Ingegerd Adlerberth, Agnes E. Wold, Dan I. Andersson, Morten O. A. Sommer
Genome Dynamics of Escherichia coli during Antibiotic Treatment: Transfer, Loss, and Persistence of Genetic Elements In situ of the Infant Gut
published pages: , ISSN: 2235-2988, DOI: 10.3389/fcimb.2017.00126
|Frontiers in Cellular and Infection Microbiology 7||2019-05-29|
Lejla Imamovic, Mostafa Mostafa Hashim Ellabaan, Ana Manuel Dantas Machado, Linda Citterio, Tune Wulff, Soren Molin, Helle Krogh Johansen, Morten Otto Alexander Sommer
Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections
published pages: 121-134.e14, ISSN: 0092-8674, DOI: 10.1016/j.cell.2017.12.012
Ida Lauritsen, Andreas Porse, Morten O. A. Sommer, Morten H. H. NÃ¸rholm
A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
published pages: , ISSN: 1475-2859, DOI: 10.1186/s12934-017-0748-z
|Microbial Cell Factories 16/1||2019-05-29|
Leonie J. Jahn, Christian Munck, Mostafa M. H. Ellabaan, Morten O. A. Sommer
Adaptive Laboratory Evolution of Antibiotic Resistance Using Different Selection Regimes Lead to Similar Phenotypes and Genotypes
published pages: , ISSN: 1664-302X, DOI: 10.3389/fmicb.2017.00816
|Frontiers in Microbiology 8||2019-05-29|
Rachel A. Hickman, Christian Munck, Morten O. A. Sommer
Time-Resolved Tracking of Mutations Reveals Diverse Allele Dynamics during Escherichia coli Antimicrobial Adaptive Evolution to Single Drugs and Drug Pairs
published pages: , ISSN: 1664-302X, DOI: 10.3389/fmicb.2017.00893
|Frontiers in Microbiology 8||2019-05-29|
Rebecca M. Lennen, Annika I. NilssonÂ Wallin, Margit Pedersen, Mads Bonde, Hao Luo, Markus J. HerrgÃ¥rd, MortenÂ O.Â A. Sommer
Transient overexpression of DNA adenine methylase enables efficient and mobile genome engineering with reduced off-target effects
published pages: e36-e36, ISSN: 0305-1048, DOI: 10.1093/nar/gkv1090
|Nucleic Acids Research 44/4||2019-05-29|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIMITMDR" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LIMITMDR" are provided by the European Opendata Portal: CORDIS opendata.